These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 23937983)
21. In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR). Máté G; Kertész I; Enyedi KN; Mező G; Angyal J; Vasas N; Kis A; Szabó É; Emri M; Bíró T; Galuska L; Trencsényi G Eur J Pharm Sci; 2015 Mar; 69():61-71. PubMed ID: 25592229 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer. Yu Z; Carlucci G; Ananias HJ; Dierckx RA; Liu S; Helfrich W; Wang F; de Jong IJ; Elsinga PH Amino Acids; 2013 Feb; 44(2):543-53. PubMed ID: 22833158 [TBL] [Abstract][Full Text] [Related]
23. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells. Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271 [TBL] [Abstract][Full Text] [Related]
24. In vivo optical imaging of CD13/APN-expression in tumor xenografts. von Wallbrunn A; Waldeck J; Höltke C; Zühlsdorf M; Mesters R; Heindel W; Schäfers M; Bremer C J Biomed Opt; 2008; 13(1):011007. PubMed ID: 18315356 [TBL] [Abstract][Full Text] [Related]
25. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice. Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885 [TBL] [Abstract][Full Text] [Related]
26. Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy. Schmitt C; Voegelin M; Marin A; Schmitt M; Schegg F; Hénon P; Guenot D; Tarnus C Bioorg Med Chem; 2013 Apr; 21(7):2135-44. PubMed ID: 23428964 [TBL] [Abstract][Full Text] [Related]
27. cNGR: a novel homing sequence for CD13/APN targeted molecular imaging of murine cardiac angiogenesis in vivo. Buehler A; van Zandvoort MA; Stelt BJ; Hackeng TM; Schrans-Stassen BH; Bennaghmouch A; Hofstra L; Cleutjens JP; Duijvestijn A; Smeets MB; de Kleijn DP; Post MJ; de Muinck ED Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2681-7. PubMed ID: 16990557 [TBL] [Abstract][Full Text] [Related]
28. Clinical significance of aminopeptidase N in non-small cell lung cancer. Tokuhara T; Hattori N; Ishida H; Hirai T; Higashiyama M; Kodama K; Miyake M Clin Cancer Res; 2006 Jul; 12(13):3971-8. PubMed ID: 16818694 [TBL] [Abstract][Full Text] [Related]
29. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression. Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors. Pan H; Yang K; Zhang J; Xu Y; Jiang Y; Yuan Y; Zhang X; Xu W J Enzyme Inhib Med Chem; 2013 Aug; 28(4):717-26. PubMed ID: 22545941 [TBL] [Abstract][Full Text] [Related]
31. Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN). Ma C; Jin K; Cao J; Zhang L; Li X; Xu W Bioorg Med Chem; 2013 Apr; 21(7):1621-7. PubMed ID: 23453219 [TBL] [Abstract][Full Text] [Related]
32. Solid phase synthesis and biological evaluation of probestin as an angiogenesis inhibitor. Pathuri G; Thorpe JE; Disch BC; Bailey-Downs LC; Ihnat MA; Gali H Bioorg Med Chem Lett; 2013 Jun; 23(12):3561-4. PubMed ID: 23664876 [TBL] [Abstract][Full Text] [Related]
33. Preparation and evaluation of a CD13/APN-targeting and hydrolase-resistant conjugate that comprises pingyangmycin and NGR motif-integrated apoprotein. Li B; Zheng YB; Li DD; Zhen YS J Pharm Sci; 2014 Apr; 103(4):1204-13. PubMed ID: 24504597 [TBL] [Abstract][Full Text] [Related]
34. NGR Tumor-Homing Peptides: Structural Requirements for Effective APN (CD13) Targeting. Graziadio A; Zanda M; Frau S; Fleming IN; Musolino M; Dall'Angelo S; Baldassarre M; Piras M Bioconjug Chem; 2016 May; 27(5):1332-40. PubMed ID: 27077642 [TBL] [Abstract][Full Text] [Related]
35. Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma. Camacho X; Machado CL; García MF; Gambini JP; Banchero A; Fernández M; Oddone N; Bertolini Zanatta D; Rosal C; Buchpiguel CA; Chammas R; Riva E; Cabral P Oncology; 2017; 92(4):229-242. PubMed ID: 28196364 [TBL] [Abstract][Full Text] [Related]
36. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Hashida H; Takabayashi A; Kanai M; Adachi M; Kondo K; Kohno N; Yamaoka Y; Miyake M Gastroenterology; 2002 Feb; 122(2):376-86. PubMed ID: 11832452 [TBL] [Abstract][Full Text] [Related]
37. The effect of different species aminopeptidase N structure on the activity screening of aminopeptidase N inhibitor. Wang X; Zhang L; Yang K; Zhang C; Zhang J; Fang H; Xu W Biol Pharm Bull; 2010; 33(10):1658-65. PubMed ID: 20930372 [TBL] [Abstract][Full Text] [Related]
38. NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: A Preclinical Review. Trencsényi G; Enyedi KN; Mező G; Halmos G; Képes Z Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628856 [TBL] [Abstract][Full Text] [Related]
39. Radiosynthesis and micro-SPECT imaging of 99mTc-dendrimer poly(amido)-amine folic acid conjugate. Zhang Y; Sun Y; Xu X; Zhu H; Huang L; Zhang X; Qi Y; Shen YM Bioorg Med Chem Lett; 2010 Feb; 20(3):927-31. PubMed ID: 20045643 [TBL] [Abstract][Full Text] [Related]
40. Discovery of bioluminogenic probes for aminopeptidase N imaging. Li J; Chen L; Wu W; Zhang W; Ma Z; Cheng Y; Du L; Li M Anal Chem; 2014 Mar; 86(5):2747-51. PubMed ID: 24490993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]